|
Pharmaceutical Technology Europe
Click on article title to view & purchase. Articles are sorted by their publication date in reverse chronological order.
Total result: 757 articles |
 Page 2 of 11 
|
Darwin's unique batch and product.
April 01, 2009
LIMS with web interface.
April 01, 2009
Misery for AstraZeneca.
March 01, 2009
Phase 0 offers advantages.
March 01, 2009
Ensuring raw material quality: this month's expert examines the most a...
March 01, 2009
Quantifying experience in powder processing: enshrined in the concept ...
March 01, 2009
Predictive modelling: putting ICH guidelines to work in process valida...
March 01, 2009
Modular clean room.
March 01, 2009
Facilitating technology transfer to your CMO: Michiel Ultee talks abou...
March 01, 2009
PAT: HPLC on the horizon? PAT guidance has been available from FDA for...
March 01, 2009
Unfavourable trial results go unpublished.
March 01, 2009
Abating counterfeit medicine fears.
March 01, 2009
Building on the promise of biotech: the productivity of the pharma ind...
March 01, 2009
Evaluating the pieces of the pharma supply chain: after a year of incr...
March 01, 2009
Public access to ADR database: EMEA opens the doors to its EudraVigila...
February 01, 2009
Learning from Lean Sigma.
February 01, 2009
Expertise meets academia.
February 01, 2009
Efficient logistic operations: this month's experts examine how regula...
February 01, 2009
Consolidation play: lower demand for contract services will reduce the...
February 01, 2009
The dream team.
February 01, 2009
Fast dissolving disintegrating tablets with isomalt: the properties of...
February 01, 2009
The four colours of biotechnology: the biotechnology sector is occasio...
January 01, 2009
The packaging connection: creating better pharmaceutical and medical p...
January 01, 2009
The preferred market?
January 01, 2009
Pharma must speed up transformation.
January 01, 2009
Easing trial woes.
January 01, 2009
Sustainability in green pharmaceutical production: reducing ecological...
January 01, 2009
Promoting a peaceful workplace: conflict between departments costs mon...
January 01, 2009
Organizational polygamy: Paul Gardiner and Andrea Sobrio explain why m...
January 01, 2009
An essential tool.
December 01, 2008
The long awaited revision: the closing date for comments to be receive...
December 01, 2008
Florida.
November 01, 2008
Michigan.
November 01, 2008
New Jersey.
November 01, 2008
Pennsylvania.
November 01, 2008
Better gene delivery vehicles?
November 01, 2008
Weathering the financial storm: Big Pharma will blossom in the credit ...
November 01, 2008
20th anniversary special feature: the impact of regulations.
November 01, 2008
France's bright biotech future.
November 01, 2008
Billions for global pharma.
November 01, 2008
The beginning of the end: the formulation, filling and signing off of ...
November 01, 2008
All change for drug distribution? Major changes in Europe and the US c...
November 01, 2008
Reaping the benefits of assay miniaturization: how replacing ELISA wit...
November 01, 2008
Get it right first time!
November 01, 2008
Rapid and convenient microsphere sizing: using a PAT instrument and pi...
November 01, 2008
Developing nanoparticle formulations of poorly soluble drugs: developi...
November 01, 2008
Manufacturing problems: this year's last surface surgery examines four...
November 01, 2008
Is REACH coming to get you? The deadline for preregistration is nigh ....
November 01, 2008
Business suicide?
October 01, 2008
Appikon's big buy out.
October 01, 2008
Deal with your R22 or risk meltdown: is your company prepared for the ...
October 01, 2008
Berko Ilac: success in small and simple.
October 01, 2008
Turkey: the new frontier; In the wake of serious economic growth, heal...
October 01, 2008
Bell Holding: a nexus in pharma.
October 01, 2008
Sanovel: from local to global.
October 01, 2008
Bilim Pharmaceuticals: Building bridges.
October 01, 2008
Eczaclbasl: the post-generics pioneer.
October 01, 2008
Adeka: ready for any challenge.
October 01, 2008
Biofarma: setting global benchmarks.
October 01, 2008
Mustafa Nevzat: making strides in major markets.
October 01, 2008
Novartis: making good on local investments.
October 01, 2008
Bozlu Group: becoming a global brand.
October 01, 2008
The Birgi Group: the in-house powerhouse.
October 01, 2008
Embil pharmaceuticals: 'the kitchen of large pharma'.
October 01, 2008
Nobel Ilac: the local multinational.
October 01, 2008
Power to the people; Jacky Law outlines how the consumer focus of US p...
October 01, 2008
Successful strategies for product optimization: identifying the critic...
October 01, 2008
CMOs must face new realities; the pharmaceutical business environment ...
October 01, 2008
Pushing for allergen labelling; should the pharmaceutical industry fac...
October 01, 2008
PVA copolymer: the new coating agent: an analysis of the properties of...
October 01, 2008
Quality by design for analytical methods for use with orally inhaled a...
October 01, 2008
Monitoring dissolved ozone in the pharmaceutical industry: traditional...
October 01, 2008
PAT--a team effort: implementing PAT projects takes more than just hir...
October 01, 2008
Dr. F. Frik: high hopes in high margin drugs.
October 01, 2008
Small company, big career: the days of a 'job for life' at a Big Pharm...
October 01, 2008
|
